Formulations for oral administration of active agents
US12239691B2 · kind B2 · utility
0Cited by
12References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2017 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Aug 17, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising a therapeutically active agent and an absorption enhancer such as NAC, NAD, 5-CNAC, 4-MOAC, 4-CNAB or a salt thereof, for use in the treatment of a condition treatable by said therapeutically active agent, are provided. The compositions are for concomitant oral administration of two or more of the unit dosage form, which form together a therapeutically effective amount of the therapeutically active agent and an effective amount of the absorption enhancer. Multi-dose compositions comprising the two or more of the unit dosage form are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.